These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature. Bisgaard H. Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044 [Abstract] [Full Text] [Related]
5. [Long-acting beta-2-adrenergic agonists in bronchospasm therapy]. Płusa T. Pol Merkur Lekarski; 1999 May; 6(35):227-31. PubMed ID: 10437387 [Abstract] [Full Text] [Related]
17. Long-acting inhaled beta2-agonists in asthma therapy. Moore RH, Khan A, Dickey BF. Chest; 1998 Apr; 113(4):1095-108. PubMed ID: 9554653 [Abstract] [Full Text] [Related]
18. Salmeterol in the treatment of chronic asthma. D'Alonzo GE, Tolep KA. Am Fam Physician; 1997 Aug; 56(2):558-62. PubMed ID: 9262535 [Abstract] [Full Text] [Related]
19. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists. Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P. Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371 [Abstract] [Full Text] [Related]
20. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern? Lipworth BJ. Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]